Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

A decision is expected in the fourth quarter of 2025.

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

New research has revealed that the injections for weight loss might be doing something much bigger inside your body.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...